← Back to Search

Lifestyle Intervention for Obesity

N/A
Recruiting
Led By Lisa Goldman Rosas, PhD, MPH
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Systolic blood pressure >120 mmHg or diastolic blood pressure >80 mmHg as measured by study coordinator
One or more metabolic risk factors as follows: Fasting plasma glucose of 100 to 125 mg/dL or HbA1c of 5.7 to 6.4 if detected by a recent (within the past year), documented, blood-based diagnostic test in the Electronic Health Record (EHR) in the last year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months, 12 months, 18 months, 24 months
Awards & highlights

Study Summary

This trial is testing different approaches to help Latinas who are obese and food insecure. The hope is that this will provide evidence on the best way to help this population, and also help with implementing and spreading this information.

Who is the study for?
This trial is for Latinas over 18 with obesity and food insecurity, having a BMI ≥30 kg/m2, high triglycerides or blood pressure, and other metabolic risks. Participants must be able to commit to the study for 24 months. Exclusions include recent antidepressant changes, lack of Spanish fluency, no reliable phone or internet access, plans to move away during the study period, certain medical conditions like severe comorbidities or active cancer within two years.Check my eligibility
What is being tested?
The Vida Sana y Completa study tests effective approaches for tackling obesity and food insecurity among Latina women in primary care settings. It compares two programs: 'Vida Sana' and 'Vida Sana y Completa', focusing on their potential impact on health outcomes and feasibility for broader implementation.See study design
What are the potential side effects?
As this trial focuses on lifestyle interventions rather than medications, side effects are not typical as seen with drugs but may include discomfort from dietary changes or increased physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My blood pressure is higher than 120/80 mmHg.
Select...
My blood sugar or HbA1c levels are slightly high.
Select...
My HDL cholesterol is low according to my recent health records.
Select...
I am 18 years old or older.
Select...
I am female.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months, 12 months, 18 months, 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, 12 months, 18 months, 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Weight change (12 months)
Secondary outcome measures
Bidimensional Acculturation Scale for Hispanics
COVID-19 Impact on Health and Wellbeing Survey for Health Literacy
Cardiometabolic risk factors
+16 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Vida Sana y CompletaExperimental Treatment1 Intervention
Vida Sana y Completa is an obesity intervention with integrated treatment for food insecurity. This arm includes all the activities described for the active comparator arm (Vida Sana) as well as a weekly food box delivery for the first 12 weeks of the intervention. The food box will contain approximately 40 pounds of food including proteins and dairy, whole grains, and produce. Just like the Vida Sana active comparator arm, the Vida Sana y Completa group will include health coaches who will facilitate 12 weekly 1-hour group education sessions, followed by nine 30-45 minute individual monthly phone sessions. Health coaches will also conduct two home visits (at baseline and 12-weeks post-enrollment). The health coach will review participant's fitbit health tracking data with them and give personalized feedback.
Group II: Vida SanaActive Control1 Intervention
Vida Sana is a cultural-adaption of Group Lifestyle Balance, a 12-month intervention that targets at least 5% weight loss and at least150 minutes per week of moderate-to-vigorous physical activity. Health coaches will facilitate 12 weekly 1-hour group education sessions, followed by nine 30-45 minute individual monthly phone sessions. Health coaches will also conduct two home visits (at baseline and 12-weeks post-enrollment). The health coach will review participant's fitbit health tracking data with them and give personalized feedback.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,403 Previous Clinical Trials
17,342,397 Total Patients Enrolled
69 Trials studying Obesity
269,772 Patients Enrolled for Obesity
San Mateo Medical CenterOTHER
3 Previous Clinical Trials
659 Total Patients Enrolled
1 Trials studying Obesity
207 Patients Enrolled for Obesity
Patient-Centered Outcomes Research InstituteOTHER
554 Previous Clinical Trials
29,947,939 Total Patients Enrolled
17 Trials studying Obesity
3,384,255 Patients Enrolled for Obesity

Media Library

Vida Sana Clinical Trial Eligibility Overview. Trial Name: NCT05211180 — N/A
Obesity Research Study Groups: Vida Sana, Vida Sana y Completa
Obesity Clinical Trial 2023: Vida Sana Highlights & Side Effects. Trial Name: NCT05211180 — N/A
Vida Sana 2023 Treatment Timeline for Medical Study. Trial Name: NCT05211180 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the largest number of participants that this experiment can accommodate?

"Affirmative. Per the information on clinicaltrials.gov, this medical trial is currently searching for appropriate candidates and has been since September 27th 2022. The study aims to recruit 412 patients from one location."

Answered by AI

Are there any openings available for prospective participants in this research endeavor?

"Indeed, clinicaltrials.gov shows that this research endeavour is still looking for participants. The trial was first published on September 27th 2022 and most recently updated on the same day; a total of 412 patients need to be found at 1 center."

Answered by AI
~240 spots leftby Oct 2026